03:58 AM EDT, 10/17/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said late Thursday it priced an underwritten public share offering and concurrent private placement for gross proceeds of about $135 million.

The company is offering about 15.6 million shares at a price of $8 per share. It granted underwriters a 30-day option to purchase up to an additional 2.3 million shares.

Lexeo also agreed to sell pre-funded warrants to purchase around 1.3 million shares to Balyasny Asset Management in a private placement at nearly $8 per pre-funded warrant.

The offering and the private placement are expected to close on or about Oct. 20.